Gilead Sciences stock slips as earnings estimates shift

Gilead Sciences stock (ISIN US3755581036) closed at USD 149.56 on the Nasdaq on September 22, 2026, down 0.7 percent from the prior close. The shares ended USD 7.73 below the 52-week high of USD 157.29 and remained USD 41.10 above the 52-week low of USD 108.46.

Revenue reaches USD 7.80 billion

The latest reported quarter produced revenue of USD 7.80 billion, up 10.6 percent year over year, according to MarketBeat on September 22, 2026. Revenue also exceeded the reported analyst estimate of USD 7.40 billion by USD 400 million, giving the sales figure a concrete comparison point.

The same report put quarterly EPS at negative USD 6.75, compared with a consensus estimate of negative USD 7.25, a positive difference of USD 0.50. Gilead also declared a quarterly dividend of USD 0.82 per share for the period, equivalent to USD 3.28 on an annualized basis.

Estimates move toward 2026

Erste Group Bank raised its fiscal 2026 EPS estimate to negative USD 0.44 from negative USD 0.45, while the consensus estimate stood at negative USD 0.48, according to MarketBeat on September 22, 2026. The estimate change is small in absolute terms, but it places the bank's forecast USD 0.04 above consensus.

The broader analyst picture in that report carried a Moderate Buy consensus and an average price target of USD 158.78. Relative to the September 22 close of USD 149.56, that target was USD 9.22 higher, while the stock remained below its reported 52-week high.

Stock closes below yearly high

Nasdaq data cited in the September 23, 2026 market report showed an intraday range of USD 148.71 to USD 150.56 on September 22, with 111,305 shares traded by 3:53 p.m. ET. The closing price was 4.9 percent below the 52-week high, calculated from the reported USD 149.56 close and USD 157.29 high.

For investors, the central contrast is numerical: quarterly revenue grew 10.6 percent year over year and beat the reported sales estimate by USD 400 million, while the share price still finished 4.9 percent below its yearly high. The next reported earnings date listed for Gilead is October 22, 2026, according to The Wall Street Journal.

Nasdaq close remains the reference

Gilead Sciences stock closed at USD 149.56 on the Nasdaq on September 22, 2026, after a 0.7 percent daily decline. The reported market capitalization was USD 186.69 billion as of September 22, 2026.

More news and analyses on Gilead Sciences stock